Botox and Dysport are both formulations of botulinum toxin type A, and both work by the same biological mechanism: blocking acetylcholine release at the neuromuscular junction to temporarily weaken targeted muscles. The question of Botox vs Dysport, and which is better, does not have a universal answer. The real differentiators are onset speed, diffusion pattern, unit dosing, and how those properties interact with your specific facial anatomy and treatment goals. An experienced injector selects between them based on the area being treated, the muscle characteristics, and the desired balance of precision versus spread.
Botox and Dysport: The Same Family, Different Profiles
Botulinum toxin type A is the active ingredient in both products, but they are not identical. Botox (onabotulinumtoxinA) and Dysport (abobotulinumtoxinA) are manufactured through different processes, resulting in distinct protein complexes surrounding the neurotoxin molecule. These surrounding proteins influence how the toxin moves through tissue after injection, which in turn affects diffusion, onset, and the clinical feel of the result.
Think of it this way: both products arrive at the same destination (a relaxed muscle), but they travel there by slightly different routes. Dysport’s molecular structure allows it to spread more readily through tissue, while Botox tends to stay closer to the injection site. Neither characteristic is inherently good or bad. Each becomes an advantage or a limitation depending on where on the face it is being placed and what the treatment goal is.
Why Two Products Exist at All
Patients sometimes ask why two neurotoxins are needed if they do the same thing. The answer is that clinical nuance matters in aesthetics. A product that diffuses widely can cover a broad surface area like the forehead with fewer injection points. A product that stays localized can target a specific muscle without affecting its neighbours. Having both options allows an injector to match the tool to the anatomy rather than forcing one product to serve every situation. Montreal patients who come in researching both options are often surprised to learn that the choice is less about brand loyalty and more about which physical property suits the treatment zone.
Key Clinical Differences at a Glance
The table below summarizes the practical differences that matter most when comparing Botox vs Dysport. These are general characteristics, and individual results vary based on metabolism, muscle strength, dose, and injection technique.
| Characteristic | Botox (onabotulinumtoxinA) | Dysport (abobotulinumtoxinA) |
|---|---|---|
| Active toxin | Botulinum toxin type A | Botulinum toxin type A |
| Onset of results | Typically 3 to 7 days; full effect by day 10 to 14 | Often 2 to 5 days; full effect by day 7 to 10 |
| Diffusion (tissue spread) | More localized at injection site | Greater spread through surrounding tissue |
| Duration of effect | Approximately 3 to 4 months | Approximately 3 to 4 months |
| Unit equivalence | 1 unit Botox | Roughly 2.5 to 3 units Dysport (not a 1:1 ratio) |
| Precision | Higher; ideal for small, targeted muscles | Broader coverage; ideal for larger surface areas |
| Protein load | Higher molecular weight complex | Lower molecular weight complex |
The unit equivalence row deserves special attention. Botox and Dysport are dosed on different scales, which means 50 units of Dysport is not the same as 50 units of Botox. A common conversion ratio is approximately 2.5 to 3 units of Dysport for every 1 unit of Botox, though this ratio is a clinical guideline rather than an exact formula. This is why comparing prices per unit between the two products without understanding the conversion can be misleading. A clinic quoting Dysport at a lower per-unit cost may not actually be less expensive once the dose is adjusted.
Onset and Duration: Which Works Faster and Lasts Longer?
Speed of Onset
Dysport generally takes effect faster than Botox. Most patients begin to notice softening within 2 to 5 days after Dysport treatment, compared to 3 to 7 days for Botox. The full result for Dysport is typically visible by day 7 to 10, while Botox reaches its peak around day 10 to 14. The difference is not dramatic, but it can matter for patients treating for a specific event or timeline.
The faster onset of Dysport relates to its diffusion properties. Because the product spreads more readily through tissue, it reaches a greater number of muscle fibres more quickly. Botox, staying more concentrated at the injection point, reaches fewer fibres initially but achieves a precise, controlled effect as it binds locally. Neither timeline is inherently better. A patient who wants to see results before a weekend event may prefer Dysport, while one who values a gradual, subtle onset may prefer the slower build of Botox.
Duration of Effect
Duration is where the two products are most similar. Both Botox and Dysport typically last approximately 3 to 4 months, with individual variation based on metabolism, muscle strength, dose, and how long you have been receiving treatment. Some patients report that Dysport wears off slightly sooner, while others find it lasts equally well. The clinical literature does not show a consistent, significant difference in duration between the two when dosed at an appropriate conversion ratio.
What does affect duration is the dose. A conservative dose, whether Botox or Dysport, will generally wear off sooner than a full dose. This is the tradeoff explained in our frown lines Botox guide: lower doses preserve more natural movement but may require more frequent maintenance. The decision between products is separate from the decision about dose. You can choose Dysport and still opt for a conservative approach, or choose Botox and request a standard dose. These are independent clinical decisions.
Spread and Diffusion: Why It Matters by Treatment Area
Diffusion is the single most clinically significant difference between Botox and Dysport, and it is the property that most directly influences which product an experienced injector selects for a given area. Diffusion refers to how far the neurotoxin travels through tissue after injection. Botox stays relatively close to where it is placed. Dysport spreads more broadly, affecting a wider radius of muscle around each injection point.
Where Diffusion Is an Advantage
For broad, thin muscle areas like the forehead (frontalis muscle), Dysport’s wider spread can be beneficial. The frontalis is a wide, fan-shaped muscle that creates horizontal forehead lines. Treating it effectively requires even coverage across a relatively large surface. Dysport’s diffusion allows fewer injection points to achieve smooth, consistent softening across the forehead, which can mean a quicker treatment and potentially less discomfort.
Where Precision Is an Advantage
For small, targeted muscles where precision is critical, Botox’s localized spread is often preferred. The glabellar complex (the muscles between the brows that create the 11s) is a good example. These muscles sit close to the brow and eyelid, and unwanted diffusion into adjacent structures can cause a heavy brow or a drooping eyelid. Botox’s tendency to stay where it is placed gives the injector more control over exactly which muscle fibres are affected.
Similarly, for masseter treatment used in non-surgical jawline contouring, precision matters. The masseter is a large muscle, but the injection must be placed within the safe zone of that muscle to avoid affecting the risorius or other muscles involved in smiling. An injector’s product choice here depends on their assessment of the muscle’s size, the patient’s anatomy, and the degree of slimming desired.
The Injector’s Role in Managing Diffusion
Diffusion is not purely a product property. It is also influenced by dilution, injection depth, volume per injection point, and technique. A skilled injector can increase or decrease the effective spread of either product by adjusting these variables. This is why the experience and anatomical knowledge of the person holding the syringe matters at least as much as the product name on the label. The same Dysport that spreads widely in one injector’s hands can be placed with considerable precision by another who adjusts dilution and technique accordingly.
Which Neurotoxin Is Better for Your Specific Goals?
The most honest answer is that neither Botox nor Dysport is categorically better. The right choice depends on which area is being treated, the thickness and strength of the target muscle, your anatomy, and your priorities regarding onset speed, precision, and natural movement. Below are the general patterns an experienced injector considers when selecting between them.
For Frown Lines (Glabellar 11s)
The glabellar complex involves small, specific muscles sitting in a tight anatomical space near the brow and eyelid. Precision is paramount. Botox is often the default choice here because its localized spread reduces the risk of unwanted diffusion into adjacent structures. That said, Dysport can be used effectively in this area by an injector who adjusts dilution and placement to control spread. The decision often comes down to injector preference and the patient’s muscle anatomy. Our detailed guide to frown lines Botox for the 11s covers how these muscles are assessed and why conservative dosing matters regardless of which product is selected.
For Forehead Lines
The frontalis muscle spans the width of the forehead, and even coverage is the goal. Dysport’s broader diffusion can be advantageous here, allowing smooth softening across the forehead with fewer injection points. However, the frontalis also requires careful dosing because overtreating it can cause a brow droop. The injector must balance the benefit of spread against the risk of the product reaching muscles it should not. Both products are used successfully in this area; the choice depends on the injector’s technique and the patient’s forehead anatomy.
For Crow’s Feet (Lateral Orbital Lines)
Crow’s feet are created by the orbicularis oculi, a circular muscle around the eye. Treatment here requires precision because the muscle is thin and sits close to the eye. Botox’s localized spread is often favoured for this delicate area, though Dysport is also used by injectors who are experienced with its diffusion characteristics. The patient’s muscle pattern and the degree of asymmetry between the two sides also factor into the decision.
For Masseter Slimming and Jaw Tension
The masseter is a large, thick muscle, and treatment requires precise placement within a defined safe zone. As discussed in our article on jawline contouring with filler and neurotoxin, the goal is to reduce the muscle’s bulk without affecting adjacent muscles that control smiling. Botox is commonly used for masseter treatment because its localized spread keeps the effect within the target zone. However, some injectors prefer Dysport for larger muscles where some diffusion is acceptable. The muscle’s size and the patient’s specific anatomy guide this choice.
For First-Time Patients
First-time injectable patients often feel overwhelmed by the number of decisions: which product, which areas, what dose. The reassuring reality is that for a first treatment, the injector’s skill and your comfort with the process matter more than the specific product. A conservative approach with either Botox or Dysport, placed by an injector who understands your anatomy, will produce a natural, refreshed result. If you have a specific timeline concern (wanting results before an event), Dysport’s faster onset may be a consideration. If you want the most gradual, subtle onset possible, Botox may feel more comfortable. Neither choice locks you in permanently. Many patients try one product and switch later based on how their body responds.
The Consultation: Where the Decision Belongs
The decision between Botox and Dysport should be made during a consultation, not in advance. Fahimeh approaches this as a diagnostic conversation: assessing your muscle activity at rest and in motion, evaluating skin quality, considering which areas of concern are truly muscular versus structural, and determining which product properties align with your anatomy and goals. The consultation at FAH Signature Clinique is not a sales appointment. It is a clinical assessment where the honest answer may be to treat one area with Botox and another with Dysport, to treat conservatively with either, or to advise that neurotoxin is not the right tool for your concern at all.
Restraint is part of safe practice. Some patients are better served by treating the cheek first, others by addressing skin quality, and some by waiting. A practitioner who is willing to say no, or to recommend a different approach entirely, is one who prioritizes your outcome over product volume. That willingness is one of the clearest signs that your injector is working in your interest.
If you are in the early stages of research or ready to discuss a treatment plan, we welcome the conversation. Book a consultation with Fahimeh at FAH Signature Clinique on Nun’s Island to determine whether Botox or Dysport is the right next step for your goals. You may leave with a personalized plan that uses one or both products strategically, or with the honest answer that neurotoxin is not the right fit for you yet. Each of those outcomes is a valid clinical decision, and the goal is always a refreshed version of your own face, not someone else’s.
Frequently Asked Questions
Is Botox or Dysport better for treating wrinkles?
Neither product is categorically better. Both are botulinum toxin type A and produce similar results. The key differences are onset speed (Dysport is typically faster), diffusion (Dysport spreads more broadly, Botox is more localized), and unit dosing (they are not equivalent on a 1:1 basis). The right choice depends on the treatment area, your anatomy, and your injector’s assessment.
How many units of Dysport equal one unit of Botox?
There is no fixed conversion ratio, but a common clinical guideline is approximately 2.5 to 3 units of Dysport for every 1 unit of Botox. This means comparing per-unit prices between the two products without accounting for the conversion can be misleading. The appropriate dose is determined during consultation based on muscle strength and treatment area.
Which neurotoxin works faster, Botox or Dysport?
Dysport generally takes effect faster, with results appearing in 2 to 5 days and full effect by day 7 to 10. Botox typically begins working in 3 to 7 days with full results by day 10 to 14. The difference is modest but can matter if you are treating before a specific event.
Does Botox or Dysport last longer?
Both typically last 3 to 4 months. Duration is influenced more by dose, metabolism, and muscle strength than by the specific product. Some patients feel one lasts longer for them personally, but clinical studies do not show a consistent significant difference when the products are dosed at an appropriate conversion ratio.
Can Botox and Dysport be used in different areas of the same face?
Yes. Dysport’s broader diffusion can be advantageous for large surface areas like the forehead, where even coverage matters. Botox’s localized spread is often preferred for small, precise areas like the glabellar muscles between the brows or the delicate muscles around the eyes. An experienced injector may use both strategically depending on the treatment zone.
